http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CS-237711-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bf641a7774560f21f0622923bbcc186c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_db9595c960aa63eca13dbbbab70315e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5351c7c7495a9590a04172e9e70afbd1
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D475-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D475-08
filingDate 1983-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ab51218f706612a46f9b73d727558e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbbf2449fd9085589d61b73769102faf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bce04262e73d745b18851b66c690ecd
publicationDate 1985-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CS-237711-B1
titleOfInvention Process for the preparation of 6,10-methenyl-5,6,7,8-tetrahedyric acid
abstract The subject of the invention is a production methodn5,10-aetenyl-5,6,7,8-tetrahydrofolic acidnwhich is a precursor of leucovorin,nused as an antidotencytostatics of methotrexate or in the lure 'ndisorders of folic acid metabolism. Disadvantagesncurrent proceduresna process for the production of 5,10-methenyl-5,6,n7,8-tetrahydrofolic acid by reduction of the acidnfoliar hydrogen on the hydrogenation catalystnin aqueous medium and subsequentn5,6,7,8-tetrahydrofolic acid formlaclnformic acid, whereinnthe formylation is carried out in an inert atmosphere,neg under nitrogen, directly in the rection mixturenafter reduction while maintaining the resulting mixturenat 20 to 100 ° C for 0.1 ton8 hours and then 5,10-methenyl-n-5,6,7,8-tetrahydrofolic acid is isolated.
priorityDate 1983-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135402046
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82844
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414803645
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415966245
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135405047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414854641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450418934
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407631466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590027
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135444742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398657
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505489
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552576
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135403648
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518250

Total number of triples: 42.